Stephen A.  Trowbridge net worth and biography

Stephen Trowbridge Biography and Net Worth

Stephen A. Trowbridge was appointed Executive Vice President and Chief Financial Officer in February 2020, having served as Interim Chief Financial Officer since October 2019. Prior to his appointment as Chief Financial Officer, he served as the Company’s Senior Vice President and General Counsel. He joined AngioDynamics in June 2008 as Corporate Counsel. 

In addition to serving as the Company’s CFO and managing the finance functions,
Mr. Trowbridge also manages the Legal function on an interim basis. Mr. Trowbridge also oversees the Company’s clinical affairs, medical affairs and healthcare economics departments. Prior to AngioDynamics, Mr. Trowbridge served as Corporate Counsel at Philips Healthcare and Intermagnetics General Corporation. 

Mr. Trowbridge began his career with Cadwalader, Wickersham & Taft LLP in the firm’s Mergers and Acquisitions and Securities Group. Mr. Trowbridge received a Bachelor of Science in Science and Technology Studies from Rensselaer Polytechnic Institute, a Juris Doctor from the University of Pennsylvania Law School, and a Master of Business Administration from Duke University’s Fuqua School of Business.

What is Stephen A. Trowbridge's net worth?

The estimated net worth of Stephen A. Trowbridge is at least $517,778.18 as of October 12th, 2022. Mr. Trowbridge owns 89,581 shares of AngioDynamics stock worth more than $517,778 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Trowbridge may own. Additionally, Mr. Trowbridge receives an annual salary of $528,020.00 as CFO at AngioDynamics. Learn More about Stephen A. Trowbridge's net worth.

How old is Stephen A. Trowbridge?

Mr. Trowbridge is currently 50 years old. There are 7 older executives and no younger executives at AngioDynamics. The oldest executive at AngioDynamics is Mr. James C. Clemmer, CEO, President & Director, who is 60 years old. Learn More on Stephen A. Trowbridge's age.

What is Stephen A. Trowbridge's salary?

As the CFO of AngioDynamics, Inc., Mr. Trowbridge earns $528,020.00 per year. There are 2 executives that earn more than Mr. Trowbridge. The highest earning executive at AngioDynamics is Mr. James C. Clemmer, CEO, President & Director, who commands a salary of $982,920.00 per year. Learn More on Stephen A. Trowbridge's salary.

How do I contact Stephen A. Trowbridge?

The corporate mailing address for Mr. Trowbridge and other AngioDynamics executives is 14 PLAZA DRIVE, LATHAM NY, 12110. AngioDynamics can also be reached via phone at (518) 795-1400 and via email at [email protected]. Learn More on Stephen A. Trowbridge's contact information.

Has Stephen A. Trowbridge been buying or selling shares of AngioDynamics?

Stephen A. Trowbridge has not been actively trading shares of AngioDynamics during the last quarter. Most recently, on Wednesday, October 12th, Stephen A. Trowbridge bought 1,083 shares of AngioDynamics stock. The stock was acquired at an average cost of $13.82 per share, with a total value of $14,967.06. Following the completion of the transaction, the chief financial officer now directly owns 89,581 shares of the company's stock, valued at $1,238,009.42. Learn More on Stephen A. Trowbridge's trading history.

Who are AngioDynamics' active insiders?

AngioDynamics' insider roster includes Chad Campbell (SVP), Scott Centea (VP), James Clemmer (CEO), James Clemmer (CEO), Dave Helsel (SVP), and Stephen Trowbridge (CFO). Learn More on AngioDynamics' active insiders.

Are insiders buying or selling shares of AngioDynamics?

During the last twelve months, AngioDynamics insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $67,000.00. The most recent insider tranaction occured on April, 8th when CEO James C Clemmer bought 10,000 shares worth more than $67,000.00. Insiders at AngioDynamics own 5.1% of the company. Learn More about insider trades at AngioDynamics.

Information on this page was last updated on 4/8/2024.

Stephen A. Trowbridge Insider Trading History at AngioDynamics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2022Buy1,083$13.82$14,967.0689,581View SEC Filing Icon  
1/12/2022Buy1,000$22.64$22,640.00View SEC Filing Icon  
8/11/2020Buy1,013$9.38$9,501.9460,273View SEC Filing Icon  
4/25/2016Sell12,940$12.30$159,162.0032,469View SEC Filing Icon  
See Full Table

Stephen A. Trowbridge Buying and Selling Activity at AngioDynamics

This chart shows Stephen A Trowbridge's buying and selling at AngioDynamics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AngioDynamics Company Overview

AngioDynamics logo
AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Read More

Today's Range

Now: $5.78
Low: $5.72
High: $5.85

50 Day Range

MA: $5.92
Low: $5.27
High: $7.03

2 Week Range

Now: $5.78
Low: $5.26
High: $11.38

Volume

373,060 shs

Average Volume

574,792 shs

Market Capitalization

$231.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66